Innovation Pharmaceuticals Inc (IPIX)

[xoc]

Brilicidin is being tested as a potential therapeutic with antiviral potential and as part of a vaccine.

As part of the vaccine it will be an adjuvant, not a vaccine by itself.

This in immunological terms means it will hopefully sensitize the immune system, making the immune system have a stronger response to the covid antigen,more likely to produce significant antibodies, as part of a vaccine that will also have an antigen derived from the covid 19 virus.